OTHER INFORMATION
−Removed: Restated By-Laws
−Removed: On October 26, 2022, the Board of Directors of the Company unanimously adopted Restated By-Laws of the Company (the "By-Laws") to provide that a stockholder proposing to nominate an individual for election or reelection as a director must also include, in the related notice, a representation regarding whether such stockholder intends to solicit proxies in support of director nominees other than the Company's nominees in accordance with Rule 14a-19 ("Rule") under the Exchange Act.
−Removed: To the extent such stockholder provides notice pursuant to the Rule and subsequently fails to comply with the requirements of the Rule, then the Company shall disregard any proxies or votes solicited for such nominees.
+Added: The information contained under "Supplemental Pharmacy Benefit Management Model Disclosure" in Exhibit 20.1 to this Form 10-Q is incorporated herein by reference.
INDEX TO EXHIBITS
Number Description Method of Filing
−Removed: 3.2 Restated By-Laws of Cigna Corporation dated October 26, 2022
−Removed: Filed by the registrant as Exhibit 3.2 to the Current Report on Form 8-K on October 28, 2022 and incorporated herein by reference.
−Removed: 31.1 Certification of Chief Executive Officer of Cigna Corporation pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
+Added: 3.1 Restated Certificate of Incorporation of The Cigna Group
Filed herewith.
−Removed: 31.2 Certification of Chief Financial Officer of Cigna Corporation pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
+Added: 3.2 Amended and Restated By-laws of The Cigna Group
+Added: Filed by the registrant as Exhibit 3.3 to the Current Report on Form 8-K on February 13, 2023.
+Added: 4.1(g) Supplemental Indenture No.
+Added: 6 dated as of March 7, 2023, between The Cigna Group and U.S.
+Added: Bank Trust Company, National Association, as trustee
+Added: Filed by the registrant as Exhibit 4.1 to the Current Report on Form 8-K on March 7, 2023 and incorporated herein by reference.
+Added: 10.31 Offer letter for Noelle Eder dated July 22, 202 0
Filed herewith.
−Removed: 32.1 Certification of Chief Executive Officer of Cigna Corporation pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C.
+Added: 20.1 Supplemental Pharmacy Benefit Management Model Disclosure
+Added: Filed herewith.
+Added: 31.1 Certification of Chief Executive Officer of The Cigna Group pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
+Added: Filed herewith.
+Added: 31.2 Certification of Chief Financial Officer of The Cigna Group pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
+Added: Filed herewith.
+Added: 32.1 Certification of Chief Executive Officer of The Cigna Group pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C.
Furnished herewith.
−Removed: 32.2 Certification of Chief Financial Officer of Cigna Corporation pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C.
+Added: 32.2 Certification of Chief Financial Officer of The Cigna Group pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C.
Furnished herewith.
−Removed: 101 The following materials from Cigna Corporation's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in inline XBRL (eXtensible Business Reporting Language):
+Added: 101 The following materials from The Cigna Group's Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language):
(i) the Consolidated Statements of Income;
5 unchanged sentences
Filed herewith.
−Removed: 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) Filed herewith.
+Added: 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101) Filed herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: November 3, 2022
−Removed: CIGNA CORPORATION
+Added: THE CIGNA GROUP
Executive Vice President and
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.